Virus-like particles from plant viruses and bacteriophages are emerging platform technologies for the delivery of nucleic acid therapeutics.
Kim et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: